<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>SPARK NS &#8211; UF Innovate</title>
	<atom:link href="https://innovate.research.ufl.edu/tag/spark-ns/feed/" rel="self" type="application/rss+xml" />
	<link>https://innovate.research.ufl.edu</link>
	<description>Building business on innovation</description>
	<lastBuildDate>Tue, 12 Aug 2025 04:41:38 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://innovate.research.ufl.edu/wp-content/uploads/favicon-blue_1.png</url>
	<title>SPARK NS &#8211; UF Innovate</title>
	<link>https://innovate.research.ufl.edu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>UF Scientist’s Parkinson’s Work Selected for Innovative Drug Development Effort</title>
		<link>https://innovate.research.ufl.edu/matthew-disney-selected-parkinsons-disea/</link>
		
		<dc:creator><![CDATA[sooyoungryu]]></dc:creator>
		<pubDate>Fri, 23 Aug 2024 00:00:00 +0000</pubDate>
				<category><![CDATA[News Brief]]></category>
		<category><![CDATA[Tech Licensing]]></category>
		<category><![CDATA[UF Innovate]]></category>
		<category><![CDATA[UF Inventors]]></category>
		<category><![CDATA[Herbert Wertheim UF Scripps Institute]]></category>
		<category><![CDATA[Matthew Disney]]></category>
		<category><![CDATA[Parkinson&#039;s disease]]></category>
		<category><![CDATA[RNA-targeted medicines]]></category>
		<category><![CDATA[SPARK NS]]></category>
		<guid isPermaLink="false">https://scaddev1.com/matthew-disney-selected-parkinsons-disea/</guid>

					<description><![CDATA[University of Florida chemist Matthew Disney, Ph.D., was selected for an ambitious two-year effort to move promising Parkinson’s disease discoveries to patients.]]></description>
										<content:encoded><![CDATA[
<p>People with Parkinson’s need better treatment options, and they need them fast. A California nonprofit, SPARK NS, announced Tuesday that it has selected University of Florida chemist Matthew Disney, Ph.D., for an ambitious two-year effort to move promising Parkinson’s disease discoveries to patients.</p>



<p>Disney, chemistry department chair and Institute Professor at The Herbert Wertheim UF Scripps Institute for Biomedical Innovation &amp; Technology, has pioneered ways to create RNA-targeted medicines. He is one of five scientists nationally whose projects were selected. The nonprofit will supply each scientist with up to $2 million and the expertise of more than 50 scientific and business advisers experienced in bringing new medicines to patients.</p>



Read more about <a href="https://ufhealth.org/news/2024/uf-scientists-parkinsons-work-selected-for-innovative-drug-development-effort"> UF Scientist’s Parkinson’s Work Selected for Innovative Drug Development Effort. </a>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
